HUILE CBD FULL SPECTRUM 15% 10ML

Presentation of the CBD Oil 15% Full Spectrum 10mL

CBD Oil 15% Full Spectrum 10mL - Swiss CBD Quality

SWISS MEDICAL CANNABIS SA. has selected the best hemp genetics from the European catalog and produced in organic culture.

The CBD 15% oil is made from cannabinoids extracted with supercritical CO2. This method of extraction makes it possible to preserve a quality and a perfect purity of the whole spectrum of the cannabinoids (being part of the oils regarded as "Full spectrum").

Our extractions are tested and contain no heavy metals or other pollutants. All our oils are 100% organic, guaranteed without pesticides or herbicides. We use the term "organic" because some of our flower production is done indoors, which prevents us from claiming the organic label because of the use of electric lights.

Also our products are 100% vegetable origin and are not tested on animals, so they can benefit from the claim of "vegan" products.

Benefits of the ingredients of the CBD Oil 15% Full Spectrum 10mL

The CBD oil 15% SMC Laboratories® is composed of natural elements of the plant

Cannabis Sativa L.including the different phytocannabinoids: Cannabidiol (CBD), Cannabichromene (CBC), Cannabigerol (CBG)and Cannabinol (CBN).

It also contains terpenes, including myrcene, limonene, alpha and beta pinene, linalool, B-caryophyllene, caryophyllene oxide, humulene, nerolidol and phytol.

CBD 15% oil contains other natural molecules: alkanes, nitrogen compounds, amino acids, sugars, aldehydes, ketones, flavonoids, glucosides, vitamins, pigments and is stabilized in hemp seed oil.

Taux de THC : < 0,2% conformément aux réglementations en vigueur.

Usage CBD Oil 15% Full Spectrum 10mL

Our company SWISS MEDICAL CANNABIS SA. is subject to the various legislations, Swiss and European, formally prohibiting to praise the benefits of cannabis and its derivatives. We are therefore not in a legal position to give you medical advice or recommendations for use.

On the other hand, you can learn more about the generalities about cannabinoids in theCBD Blog section of our website.

All our articles are written by our team of experts on cannabinoids and their applications. The facts transcribed through our CBD Blog are taken from the international scientific literature, whose sources are verifiable and quoted at the end of each of our articles by following the link below:

Our cosmetic products are for skin application only, they do not have any biocidal effect, nor do they have curative, lenitive or preventive properties, such as medicinal or therapeutic properties, nor do they have disinfectant or anti-inflammatory effects, nor are they recommended by a member of the medical profession. Do not ingest cosmetic products. SWISS MEDICAL CANNABIS SA. declines all responsibility for the misuse of its products.

1 Drop = 7.5mg of CBD

1 ml = 20 Drops

1 Bottle = 10ml = mini 200 Drops

Ex: If 2 drops at 15% / day = 15mg = 100 days of use.

Store in a cool & dry place and use within 6 months after opening.

The classification "Food Supplement" is PROHIBITED.

The CBD oils of classification "Chemical product" contain an additive making them unfit for consumption. Therefore, we do not sell them.

They are specifically designed to meet the highest standards of Health Professionals.

The "CBD oils" products of our company SWISS MEDICAL CANNABIS SA. benefit from Pharmacodes for parapharmaceutical products, intended for final consumers. Referenced by the company HCI SOLUTION, these Pharmacodes attest to the respect of good procedures for the marketing of our products. Our CBD oils can be freely sold by health professionals to their customers.

All of these data are the property of SWISS MEDICAL CANNABIS SA. by virtue of the 91/250/EEC and 96/9/EC directives which grant copyright protection to computer programs and databases respectively. SWISS MEDICAL CANNABIS SA. reserves the right to take legal action competent in connection with any copy or reproduction of our information.

We also reserve the right to file a claim for damages, in accordance with article L. 331-1-3 of the CPI, which states that "in order to determine the damages, the court shall take into consideration the negative economic consequences, including loss of earnings, suffered by the injured party, the profits made by the infringer and the moral prejudice caused to the owner of these rights as a result of the infringement.